![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United Kingdom | Publication | March 2024
On March 5, 2024, the Regulator published a consultation on the statement of strategy for DB schemes. Producing a statement is a fundamental part of trustees’ obligations under the new Funding and Investment Regulations which come into force on April 6, 2024.
In its consultation, the Regulator is seeking views from trustees and advisers on its proposed approach to the statement, including its proposed form and the type and extent of the information that will need to be submitted by trustees.
The Regulator provides a link for DB scheme trustees to complete an online survey and requests responses by April 16, 2024.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023